PT2467401T - Anticorpos para a deteção de complexos de integrina em material ffpe - Google Patents
Anticorpos para a deteção de complexos de integrina em material ffpeInfo
- Publication number
- PT2467401T PT2467401T PT107495939T PT10749593T PT2467401T PT 2467401 T PT2467401 T PT 2467401T PT 107495939 T PT107495939 T PT 107495939T PT 10749593 T PT10749593 T PT 10749593T PT 2467401 T PT2467401 T PT 2467401T
- Authority
- PT
- Portugal
- Prior art keywords
- antibodies
- detection
- ffpe material
- integrin complexes
- integrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09010666 | 2009-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2467401T true PT2467401T (pt) | 2017-04-26 |
Family
ID=42813245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT107495939T PT2467401T (pt) | 2009-08-19 | 2010-07-15 | Anticorpos para a deteção de complexos de integrina em material ffpe |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8420348B2 (pt) |
| EP (1) | EP2467401B1 (pt) |
| JP (1) | JP5734978B2 (pt) |
| KR (1) | KR101606236B1 (pt) |
| CN (1) | CN102597001B (pt) |
| AU (1) | AU2010285265B2 (pt) |
| CA (1) | CA2771441C (pt) |
| DK (1) | DK2467401T3 (pt) |
| EA (1) | EA032728B1 (pt) |
| ES (1) | ES2622487T3 (pt) |
| HK (1) | HK1173455A1 (pt) |
| IL (1) | IL218119A (pt) |
| MX (1) | MX2012001741A (pt) |
| PT (1) | PT2467401T (pt) |
| SG (1) | SG178348A1 (pt) |
| WO (1) | WO2011020529A2 (pt) |
| ZA (1) | ZA201201990B (pt) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2570731T3 (es) | 2008-08-05 | 2016-05-20 | Toray Industries | Método de detección de cáncer |
| KR101667319B1 (ko) | 2008-08-05 | 2016-10-18 | 도레이 카부시키가이샤 | 암의 치료 및 예방용 의약 조성물 |
| PL2532365T3 (pl) | 2010-02-04 | 2016-12-30 | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi | |
| AU2011211699B2 (en) | 2010-02-04 | 2015-01-22 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| CA2788720C (en) | 2010-02-04 | 2019-08-20 | Takayoshi Ido | Medicament for treating and/or preventing cancer |
| MX352025B (es) | 2011-02-11 | 2017-11-07 | Merck Patent Gmbh | Anticuerpo anti-integrina alfa v para el tratamiento de cancer de prostata. |
| ES2609846T3 (es) | 2011-08-04 | 2017-04-24 | Toray Industries, Inc. | Composición farmacéutica para el tratamiento y/o prevención del cáncer pancreático |
| EP2740793B1 (en) | 2011-08-04 | 2017-11-29 | Toray Industries, Inc. | Drug composition for cancer treatment and/or prevention |
| EP2740796B1 (en) | 2011-08-04 | 2017-05-17 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| MX348581B (es) | 2011-08-04 | 2017-06-20 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion de cancer. |
| DK2740795T3 (en) | 2011-08-04 | 2017-01-16 | Toray Industries | Pharmaceutical composition for the treatment and / or prevention of cancer |
| MX349907B (es) | 2011-08-04 | 2017-08-18 | Toray Industries | Metodo para detectar cancer pancreatico. |
| WO2013018891A1 (ja) | 2011-08-04 | 2013-02-07 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| RU2614252C2 (ru) * | 2011-08-17 | 2017-03-24 | Те Риджентс Оф Те Юниверсити Оф Калифорния | Антитела, которые связывают интегрин альфа-v бета-8 |
| KR102009238B1 (ko) | 2012-02-21 | 2019-08-09 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| PL2818483T3 (pl) | 2012-02-21 | 2018-01-31 | Toray Industries | Kompozycja lecznicza do leczenia i/lub zapobiegania nowotworowi |
| RU2633505C2 (ru) | 2012-02-21 | 2017-10-12 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
| DK2818481T3 (da) | 2012-02-21 | 2019-10-14 | Toray Industries | Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer |
| MX357965B (es) | 2012-03-30 | 2018-08-01 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar. |
| KR102155531B1 (ko) | 2012-03-30 | 2020-09-15 | 도레이 카부시키가이샤 | 간암의 치료 및/또는 예방용 의약 조성물 |
| WO2014014082A1 (ja) | 2012-07-19 | 2014-01-23 | 東レ株式会社 | 癌の検出方法 |
| CN104471404B (zh) | 2012-07-19 | 2017-03-01 | 东丽株式会社 | 癌的检测方法 |
| KR102351838B1 (ko) | 2013-08-05 | 2022-01-18 | 트위스트 바이오사이언스 코포레이션 | 드 노보 합성된 유전자 라이브러리 |
| WO2015020212A1 (ja) * | 2013-08-09 | 2015-02-12 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| US10351897B2 (en) | 2014-02-14 | 2019-07-16 | Bioventures, Llc | Acetaminophen adducts and methods of use thereof |
| US10626166B2 (en) * | 2014-08-22 | 2020-04-21 | Baxalta Incorporated | Detection of CHO-MIF contaminations |
| EP3009147A1 (en) | 2014-10-16 | 2016-04-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for treating resistant glioblastoma |
| AU2015358373B2 (en) | 2014-12-03 | 2021-05-27 | Arkansas Children's Research Institute | Anti-acetaminophen antibodies and acetaminophen protein adducts |
| WO2016126882A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| CA2998169A1 (en) | 2015-09-18 | 2017-03-23 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
| WO2017053450A1 (en) | 2015-09-22 | 2017-03-30 | Twist Bioscience Corporation | Flexible substrates for nucleic acid synthesis |
| WO2017182834A1 (en) | 2016-04-19 | 2017-10-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New method for treating resistant glioblastoma |
| WO2018057526A2 (en) | 2016-09-21 | 2018-03-29 | Twist Bioscience Corporation | Nucleic acid based data storage |
| CN110892485B (zh) | 2017-02-22 | 2024-03-22 | 特韦斯特生物科学公司 | 基于核酸的数据存储 |
| US10696965B2 (en) | 2017-06-12 | 2020-06-30 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| CN111566125A (zh) | 2017-09-11 | 2020-08-21 | 特韦斯特生物科学公司 | Gpcr结合蛋白及其合成 |
| CN111565834B (zh) | 2017-10-20 | 2022-08-26 | 特韦斯特生物科学公司 | 用于多核苷酸合成的加热的纳米孔 |
| WO2019084427A1 (en) * | 2017-10-27 | 2019-05-02 | Kite Pharma, Inc. | T-LYMPHOCYTE RECEPTOR ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF |
| SG11202011467RA (en) | 2018-05-18 | 2020-12-30 | Twist Bioscience Corp | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| WO2020051333A1 (en) * | 2018-09-07 | 2020-03-12 | Pfizer Inc. | Anti-avb8 antibodies and compositions and uses thereof |
| EP3898959A4 (en) * | 2018-12-21 | 2023-01-11 | Board of Regents, The University of Texas System | PHOSPHORYLATED DICER ANTIBODY AND METHODS OF USE THEREOF |
| US20220091135A1 (en) * | 2019-01-04 | 2022-03-24 | Kyoto University | Test method for ulcerative colitis and primary sclerosing cholangitis |
| SG11202109283UA (en) | 2019-02-26 | 2021-09-29 | Twist Bioscience Corp | Variant nucleic acid libraries for antibody optimization |
| US11332738B2 (en) | 2019-06-21 | 2022-05-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| US20220356238A1 (en) * | 2019-07-02 | 2022-11-10 | Astute Medical, Inc. | Antibodies and assays for ccl14 |
| CN114867746A (zh) * | 2019-08-09 | 2022-08-05 | 小利兰·斯坦福大学董事会 | 抗骨桥蛋白的治疗性抗体 |
| WO2021061842A1 (en) * | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for single domain antibodies |
| WO2021113697A1 (en) * | 2019-12-05 | 2021-06-10 | Seagen Inc. | Anti-avb6 antibodies and antibody-drug conjugates |
| CN114907468B (zh) * | 2022-06-10 | 2023-05-23 | 东莞理工学院 | 一种仿刺参整合素多克隆抗体、抗原蛋白及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02502156A (ja) * | 1987-11-19 | 1990-07-19 | スクリップス クリニック アンド リサーチ ファウンデーション | 内皮細胞のｒｇｄ指向粘着レセプターに対するモノクローナル抗体 |
| UA58482C2 (uk) * | 1994-06-08 | 2003-08-15 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти |
| EP0876507A4 (en) * | 1995-09-01 | 2003-07-30 | Univ Ramot | CONTROL AND CONTROL OF THE EXPRESSION OF THE PROTEIN PHOSPHATASE 2C-PP2C-ALPHA IN TUMOR CELLS IN TUMOR THERAPY, PREVENTION AND DETERMINATION |
| AU5150499A (en) | 1998-06-02 | 1999-12-20 | Imtox Gmbh | Rationally designed peptides, production and use thereof |
| US7163681B2 (en) * | 2000-08-07 | 2007-01-16 | Centocor, Inc. | Anti-integrin antibodies, compositions, methods and uses |
| EP1332158B1 (de) | 2000-11-08 | 2007-08-01 | Fresenius Medical Care Affina GmbH | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen |
| WO2002071928A2 (en) * | 2001-03-14 | 2002-09-19 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| AU2003217930A1 (en) | 2002-03-04 | 2003-09-22 | Medimmune, Llc | The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
| AU2003261071C1 (en) * | 2002-03-13 | 2008-12-11 | Biogen Idec Ma Inc. | Anti-AlphavBeta6 antibodies |
| CA2481922A1 (en) * | 2002-04-12 | 2003-10-23 | Raven Biotechnologies, Inc. | Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| AU2003256584A1 (en) * | 2002-07-17 | 2004-02-02 | The Center For Blood Research, Inc. | Modified proteins stabilized in a desired conformation and methods for producing same |
| CN1444043A (zh) * | 2002-12-25 | 2003-09-24 | 帕弗瑞生物技术(北京)有限公司 | 一种个体化特异性免疫细胞功能测定方法 |
| SE0301087D0 (sv) * | 2003-04-14 | 2003-04-14 | Cartela Ab | New monoclonal antibody |
| US7429487B2 (en) | 2005-07-05 | 2008-09-30 | Epitomics, Inc. | Fusion partner for production of monoclonal rabbit antibodies |
| AU2006332216A1 (en) | 2005-12-30 | 2007-07-12 | Merck Patent Gmbh | Anti-IL-6 antibodies preventing the binding of IL-6 complexed with IL-6Ralpha to gp130 |
| BRPI0815567B8 (pt) | 2007-07-17 | 2021-05-25 | Merck Patent Gessellschaft Mit Beschraenkter Haftung | anticorpos híbridos anti-alfa v-integrina projetados, proteína de fusão e composição farmacêutica |
-
2010
- 2010-07-15 JP JP2012525056A patent/JP5734978B2/ja active Active
- 2010-07-15 WO PCT/EP2010/004313 patent/WO2011020529A2/en active Application Filing
- 2010-07-15 DK DK10749593.9T patent/DK2467401T3/en active
- 2010-07-15 KR KR1020127006938A patent/KR101606236B1/ko active IP Right Grant
- 2010-07-15 EP EP10749593.9A patent/EP2467401B1/en active Active
- 2010-07-15 CA CA2771441A patent/CA2771441C/en active Active
- 2010-07-15 CN CN201080036609.4A patent/CN102597001B/zh active Active
- 2010-07-15 AU AU2010285265A patent/AU2010285265B2/en active Active
- 2010-07-15 US US13/390,791 patent/US8420348B2/en active Active
- 2010-07-15 SG SG2012009254A patent/SG178348A1/en unknown
- 2010-07-15 ES ES10749593.9T patent/ES2622487T3/es active Active
- 2010-07-15 EA EA201200281A patent/EA032728B1/ru not_active IP Right Cessation
- 2010-07-15 MX MX2012001741A patent/MX2012001741A/es active IP Right Grant
- 2010-07-15 PT PT107495939T patent/PT2467401T/pt unknown
-
2012
- 2012-02-14 IL IL218119A patent/IL218119A/en active IP Right Grant
- 2012-03-16 ZA ZA2012/01990A patent/ZA201201990B/en unknown
-
2013
- 2013-01-15 HK HK13100599.0A patent/HK1173455A1/xx unknown
- 2013-03-15 US US13/838,405 patent/US8993261B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2467401A2 (en) | 2012-06-27 |
| AU2010285265A1 (en) | 2012-04-05 |
| WO2011020529A3 (en) | 2011-06-16 |
| ES2622487T3 (es) | 2017-07-06 |
| JP5734978B2 (ja) | 2015-06-17 |
| ZA201201990B (en) | 2012-11-28 |
| WO2011020529A8 (en) | 2011-04-21 |
| WO2011020529A2 (en) | 2011-02-24 |
| AU2010285265A2 (en) | 2012-06-07 |
| DK2467401T3 (en) | 2017-03-20 |
| US20130203079A1 (en) | 2013-08-08 |
| KR20120059556A (ko) | 2012-06-08 |
| US8993261B2 (en) | 2015-03-31 |
| CN102597001A (zh) | 2012-07-18 |
| BR112012003686A2 (pt) | 2016-03-29 |
| IL218119A (en) | 2015-08-31 |
| CA2771441A1 (en) | 2011-02-24 |
| JP2013502205A (ja) | 2013-01-24 |
| US8420348B2 (en) | 2013-04-16 |
| CA2771441C (en) | 2016-10-11 |
| MX2012001741A (es) | 2012-03-21 |
| EA201200281A1 (ru) | 2012-09-28 |
| EP2467401B1 (en) | 2017-01-18 |
| SG178348A1 (en) | 2012-03-29 |
| KR101606236B1 (ko) | 2016-03-24 |
| EA032728B1 (ru) | 2019-07-31 |
| HK1173455A1 (en) | 2013-05-16 |
| AU2010285265B2 (en) | 2015-05-21 |
| CN102597001B (zh) | 2014-07-30 |
| IL218119A0 (en) | 2012-04-30 |
| US20120171699A1 (en) | 2012-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1173455A1 (en) | Antibodies for the detection of integrin complexes in ffpe material ffpe | |
| IL277166B (en) | Methods and materials for improving gastrointestinal activity | |
| IL244197A0 (en) | Antibodies against cd100 and methods of using them | |
| IL287311A (en) | Antibodies and processes for their preparation | |
| ZA201106983B (en) | Soluble "heavy-chain only" antibodies | |
| IL220390A0 (en) | Pinning nano-active material and methods for affixing the same | |
| ZA201107486B (en) | Anti-tnf-x antibodies and their uses | |
| EP2494062A4 (en) | ANTI-GLP-1R ANTIBODIES AND THEIR USES | |
| IL226801B (en) | Material for radomes and process for preparation | |
| HK1209131A1 (en) | Anti-alpha2 integrin antibodies and their uses -2 | |
| GB201011574D0 (en) | PCBN material | |
| IL220536A0 (en) | Anti - bv8 antibodies and uses thereof | |
| HK1168653A1 (en) | A-fucosylation detection in antibodies a- | |
| GB201008454D0 (en) | Material and articles formed from it | |
| EP2507263A4 (en) | ANTI-IGF-IR ANTIBODIES AND ITS USES | |
| IL214527A0 (en) | Anti-mst1r antibodies and uses thereof | |
| GB201009976D0 (en) | Material and process | |
| EP2419440A4 (en) | PEPTIDE LIGANDS FOR CLUSTERIN AND ITS USE | |
| EP2612893A4 (en) | THERMOFLUORESCENT MATERIAL AND METHOD FOR PRODUCING THE SAME | |
| GB201011579D0 (en) | PCBN material | |
| PL390642A1 (pl) | Luminofor i sposób jego otrzymywania |